Progenics Pharmaceuticals
Why Robinhood?
You can watch PGNX and buy or sell other stocks, ETFs, and their options commission-free!About PGNX
Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology.
PGNX Key Statistics
Stock Snapshot
Progenics Pharmaceuticals(PGNX) stock is priced at $4.10, giving the company a market capitalization of 355.05M. It carries a P/E multiple of -5.30.
On 2026-05-24, Progenics Pharmaceuticals(PGNX) stock opened at —, reached a high of —, and a low of —.
The Progenics Pharmaceuticals(PGNX)'s current trading volume is 0, compared to an average daily volume of 4.5M.
In the last year, Progenics Pharmaceuticals(PGNX) shares hit a 52-week high of $6.37 and a 52-week low of $1.89.
In the last year, Progenics Pharmaceuticals(PGNX) shares hit a 52-week high of $6.37 and a 52-week low of $1.89.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.